BriaCell Therapeutics Corp.
- BCTX
- NASDAQ
- Biotechnology
- Immuno-Oncology
- Cancer Immunotherapy
$3.39
Today −0.29%Quote Oct 19, 2026, 06:39 PM UTC
−19.43%over the last month
Max drawdown −21.3%From 1-month high −21.3%3 months −6.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
16
Market value
$29.5M
Quote Oct 19
Floor
$3.38
0.3% below price
Resistance
$3.43
1.2% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BCTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free